Boron compound uptake augmentation to use for neutron capture therapy.
Boron compound uptake augmentation to use for neutron capture therapy.
批准号:
17591245
负责人:
YOSHIDA Fumiyo
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
硼中子俘获疗法(BNCT)是使用硼(B^<10>)化合物和热中子的靶向放射疗法。硼帽酸钠(Sodium borocaptate,BSH)广泛应用于脑肿瘤的BNCT。我们报道了BSH摄取在体外与丁硫氨酸亚砜亚胺(BSO)组合时增强(Cancer Lett. 215(2004)61-67)。在这项研究中,我们研究了BSO对BSH在体内分布的影响。将9 L胶质肉瘤细胞接种于Fisher 344大鼠右腿皮下。2周后将大鼠分为BSO+组、BSO-组和未处理组(对照)。分别于注射后3 h、6 h和12 h处死大鼠,取脑、血液、皮下肿瘤、肌肉、皮肤、肝脏和肾脏等组织标本。血硼浓度测定结果:注射后3 h血硼浓度为55.2±15.0 μg/mg,注射后3 h血硼浓度为20.2± 14.0 μg/mg。BSO+组6 h为10.8 ±20.6 μg/mg。BSH组分别为8.1 ± 6.2 μg/mg、3.4 ± 0.5 μg/mg、1.3 ± 0.2 μg/mg。各组织中硼的浓度与血硼浓度成正比,由于BSO联合用药可维持体内高浓度硼水平,因此我们对大鼠腿部皮下肿瘤进行了BNCT。结果表明,BSO+组与BSO-组相比,肿瘤明显减少。总之,BSO在体内和体外联合使用可增强BSH的摄取。
英文摘要
Boron neutron capture therapy (BNCT) is a targeted radiation therapy using a boron (B^<10>) compound and thermal neutrons. Sodium borocaptate (BSH) is widly used for BNCT of brain tumor. We reported that BSH uptake was enhanced in combination with butionine sulfoximine (BSO) in vitro (Cancer Lett. 215 (2004) 61-67). In this study, we investigated influence of BSO on BSH distribution in vivo. 9L glicosarcoma cells were subcutaneously inoculated to right legs of Fisher 344 rats. After 2 weeks, the rats were divided into 3 groups, BSO+ group, BSO-group and untreated group (control). The rats were sacrificed at 3 hours, 6hours or 12 hours after injection, and samples of brain, blood, subcutaneous tumor, muscle, skin, liver and kidney were obtained. The results of the blood boron concentration were 55.2±15.0 μg/mg at 3 hours after injection, 20.2±14. μg/mg at 6 hours, 10.8 ±20.6 μg/mg in BSO+ group. On the other hands, in BSH only group, they were 8.1 ± 6.2 μg/rag, 3.4 ± 0.5 μg/mg, 1.3 ± 0.2 μg/mg, respectively. The boron concentration included in each tissues were in proportion to blood boron concentration.Since in vivo boron level was maintained with high concentration by BSO combination, we performed BNCT for the subcutaneous tumor which we made to the rats legs. As the result, a tumor reduced BSO+ group significantly in comparison with BSO-group.In conclusion, the uptake of BSH was enhanced in combination with BSO in vivo as well as in vitro.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoshida F(+5 authors) Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
Yoshida F(5位作者)硼和钆化合物的组合用于中子捕获疗法。
DOI:
--
发表时间:
2005
期刊:
J.Exp.Clin.Cancer Res. 24
影响因子:
--
作者:
[Matsumura A, Yamamoto T, Zhang T]
通讯作者:
Zhang T
Perfusion-weighted magnetic resonance imaging of the spinal cord in cervical spondylotic myelopathy.
脊髓型颈椎病脊髓的灌注加权磁共振成像。
DOI:
--
发表时间:
2006
期刊:
Neurol. Med. Chir. (Tokyo) 46・12
影响因子:
--
作者:
[Uemura K, Matsumura A, Isobe T (+4 authors)]
通讯作者:
Isobe T (+4 authors)
Combination of Boron and Gadolinium Compounds for Neutron Capture Therapy. An In Vitro Study.
用于中子捕获疗法的硼和钆化合物的组合。
DOI:
--
发表时间:
2005
期刊:
Clin.Cancer Res. 24
影响因子:
--
作者:
[Matsumura A, Zhang T, Nakai K, Endo K, Kumada H, Yamamoto T, Yoshida F, Sakurai F, Yamamoto K, Nose T]
通讯作者:
Nose T
Boron distribution in normal and impaired vascular tissue
正常和受损血管组织中的硼分布
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Wataro Tsuruta, Tetsuya Yamamoto, Kei Nakai, Fumiyo Yoshida, Kiyoshi Endo, Takao Tsurubuchi, Akira Matsumura]
通讯作者:
Akira Matsumura
Matsumura A Excision of juvenile pilocytic astrocytoma of the midbrain after radiotherapy.
Matsumura A 放疗后中脑幼年毛细胞星形细胞瘤的切除术。
DOI:
--
发表时间:
2006
期刊:
Pediatr.Neurosurg. 42
影响因子:
--
作者:
[Tsuboi K, Matsuda W, Nakamura K, Takano S]
通讯作者:
Takano S
共 15 条
Boron uptake enhancement by redox control in boron neutron capture therapy
-
批准号:22591605
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:YOSHIDA Fumiyo
-
依托单位:
Cell Cycle Dependence of Boron Uptake in Boron Compounds Used for Clinical Neutron Capture Therapy
-
批准号:12670852
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:2000
-
负责人:YOSHIDA Fumiyo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于FXR/FGF19通路探讨肠道BSH细菌在妊娠期肝内胆汁淤积症中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:韩振艳
-
依托单位:
约氏乳杆菌基于BSH调控SPK信号通路改善胰岛素抵抗作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:胡腾根
-
依托单位:
从BSH-胆汁酸-FXR轴研究Bifidobacterium_criceti对 小鼠脂代谢的影响及机
-
批准号:2023JJ40568
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:严思思
-
依托单位:
肠道BSH菌经回肠FXR-FGF15/19通路促进肌肉蛋白质合成在肌少症中的作用机制
-
批准号:82301762
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:邱轶轩
-
依托单位:
红芸豆多糖介导肠道BSH菌属-胆汁酸-肠FXR/TGR5轴调节糖脂代谢的作用机制
-
批准号:32302075
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:白周亚
-
依托单位:
基于肠道BSH菌群-BAs/FXR/FGF15代谢轴探讨柠檬苦素防治MAFLD作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
基于肠道BSH细菌介导的胆汁酸信号通路研究中药成分复方SC方治疗非酒精性脂肪性肝炎的作用机制
-
批准号:LY23H290004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:李红山
-
依托单位:
虎杖调控BSH细菌介导的胆汁酸代谢抑制肠FXR通路治疗高脂血症的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王敏
-
依托单位:
基于肠道BSH细菌-FXR-ASBT研究白头翁汤治疗炎症性肠病的机制
-
批准号:32260898
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:华永丽
-
依托单位:
多氏拟杆菌通过BSH酶调节胆汁酸-FXR通路抑制艰难梭菌芽孢萌发防治CDAD的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:白杨
-
依托单位: